BOLT
NASDAQ · Biotechnology
Bolt Biotherapeutics Inc
$6.17
+0.26 (+4.40%)
Open$6.04
Previous Close$5.91
Day High$6.20
Day Low$6.00
52W High$7.78
52W Low$3.10
Volume—
Avg Volume1.43M
Market Cap12.60M
P/E Ratio—
EPS$-16.44
SectorBiotechnology
Analyst Ratings
Buy
10 analysts
Price Target
+327.4% upside
Current
$6.17
$6.17
Target
$26.37
$26.37
$21.16
$26.37 avg
$30.50
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 7.93M | 7.18M | 3.98M |
| Net Income | -34,383,138 | -28,047,515 | 267.7K |
| Profit Margin | -433.7% | -412.1% | 6.7% |
| EBITDA | -35,872,781 | -30,888,373 | 477.9K |
| Free Cash Flow | — | — | 225.1K |
| Rev Growth | +10.3% | +10.3% | +11.2% |
| Debt/Equity | — | — | 0.39 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $294.45 | -0.18% | 49.3 | 509.50B |
| AMGN | Amgen Inc | $467.06 | -0.22% | 26.5 | 248.84B |
| GILD | Gilead Sciences Inc | $167.95 | -1.05% | — | 208.28B |
| VRTX | Vertex Pharmaceuticals Inc | $542.62 | -0.81% | 34.5 | 137.12B |
| REGN | Regeneron Pharmaceuticals | $951.19 | -0.86% | 19.4 | 93.39B |
| ALNY | Alnylam Pharmaceuticals Inc | $156.65 | -2.00% | 7.7 | 20.98B |